| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 3.72e-05 | 7 | 28 | 2 | GO:0007221 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.83e-04 | 96 | 28 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | P-body | 3.38e-04 | 102 | 28 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.30e-04 | 269 | 28 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | chromatin | 5.35e-04 | 1480 | 28 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.49e-04 | 287 | 28 | 4 | GO:0035770 | |
| Domain | Neuroggenic_mastermind-like_N | 5.59e-06 | 3 | 26 | 2 | IPR019082 | |
| Domain | MamL-1 | 5.59e-06 | 3 | 26 | 2 | SM01275 | |
| Domain | MamL-1 | 5.59e-06 | 3 | 26 | 2 | PF09596 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.45e-05 | 48 | 22 | 3 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 9.63e-05 | 58 | 22 | 3 | M29616 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.04e-04 | 10 | 22 | 2 | MM15535 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.52e-04 | 12 | 22 | 2 | M27159 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.52e-04 | 12 | 22 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.52e-04 | 12 | 22 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.79e-04 | 13 | 22 | 2 | M47534 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.99e-04 | 74 | 22 | 3 | M616 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.09e-04 | 14 | 22 | 2 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.75e-04 | 16 | 22 | 2 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.50e-04 | 18 | 22 | 2 | MM14775 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.34e-04 | 20 | 22 | 2 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.17e-04 | 246 | 22 | 4 | M10189 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.77e-04 | 23 | 22 | 2 | MM14954 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.82e-04 | 25 | 22 | 2 | M27880 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.97e-04 | 27 | 22 | 2 | M39545 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 8.03e-04 | 119 | 22 | 3 | M607 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.57e-04 | 28 | 22 | 2 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.19e-03 | 33 | 22 | 2 | M604 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.50e-03 | 37 | 22 | 2 | M29790 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.66e-03 | 39 | 22 | 2 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.93e-03 | 42 | 22 | 2 | M17541 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.21e-03 | 45 | 22 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.31e-03 | 46 | 22 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.41e-03 | 47 | 22 | 2 | M7946 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.41e-03 | 47 | 22 | 2 | M29777 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.51e-03 | 48 | 22 | 2 | M288 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.62e-03 | 49 | 22 | 2 | M618 | |
| Pubmed | 2.20e-09 | 152 | 28 | 6 | 38360978 | ||
| Pubmed | 6.47e-08 | 268 | 28 | 6 | 33640491 | ||
| Pubmed | ZNF611 MAML1 NCOA1 TARDBP ZBTB33 RESF1 PUM1 POLH PRRC2B TNRC6A | 8.86e-08 | 1429 | 28 | 10 | 35140242 | |
| Pubmed | RNA helicase DDX6 and scaffold protein GW182 in P-bodies promote biogenesis of stress granules. | 6.25e-07 | 2 | 28 | 2 | 37427791 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12386158 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31400113 | ||
| Pubmed | miRISC and the CCR4-NOT complex silence mRNA targets independently of 43S ribosomal scanning. | 1.87e-06 | 3 | 28 | 2 | 27009120 | |
| Pubmed | The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs. | 9.36e-06 | 6 | 28 | 2 | 25722370 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 23535175 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 28683311 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 24768540 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 12370315 | ||
| Pubmed | LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing. | 2.24e-05 | 9 | 28 | 2 | 20616046 | |
| Pubmed | The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA function. | 2.80e-05 | 10 | 28 | 2 | 23125361 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.94e-05 | 457 | 28 | 5 | 32344865 | |
| Pubmed | 3.02e-05 | 777 | 28 | 6 | 35844135 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 15546612 | ||
| Pubmed | 3.68e-05 | 80 | 28 | 3 | 35803934 | ||
| Pubmed | Cytoplasmic compartmentalization of the fetal piRNA pathway in mice. | 4.10e-05 | 12 | 28 | 2 | 20011505 | |
| Pubmed | Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. | 4.85e-05 | 13 | 28 | 2 | 28007900 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 5.92e-05 | 877 | 28 | 6 | 20211142 | |
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 7.45e-05 | 16 | 28 | 2 | 22069191 | |
| Pubmed | 8.77e-05 | 107 | 28 | 3 | 30995489 | ||
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 20059948 | ||
| Pubmed | 1.29e-04 | 122 | 28 | 3 | 36929488 | ||
| Pubmed | 1.42e-04 | 638 | 28 | 5 | 31182584 | ||
| Pubmed | 1.43e-04 | 22 | 28 | 2 | 11867769 | ||
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 9225980 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.72e-04 | 351 | 28 | 4 | 38297188 | |
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 2.01e-04 | 26 | 28 | 2 | 24391519 | |
| Pubmed | 2.08e-04 | 1103 | 28 | 6 | 34189442 | ||
| Pubmed | 2.50e-04 | 29 | 28 | 2 | 31330130 | ||
| Pubmed | 3.35e-04 | 418 | 28 | 4 | 34709266 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.19e-04 | 807 | 28 | 5 | 22681889 | |
| Pubmed | 4.26e-04 | 183 | 28 | 3 | 36129980 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.89e-04 | 462 | 28 | 4 | 31138677 | |
| Pubmed | A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. | 5.79e-04 | 44 | 28 | 2 | 32492419 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.09e-04 | 218 | 28 | 3 | 33378226 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 7.18e-04 | 49 | 28 | 2 | 27352031 | |
| Interaction | EYA4 interactions | 8.72e-07 | 243 | 28 | 6 | int:EYA4 | |
| Interaction | CELF1 interactions | 2.34e-06 | 288 | 28 | 6 | int:CELF1 | |
| Interaction | PATL1 interactions | 4.12e-06 | 177 | 28 | 5 | int:PATL1 | |
| Interaction | SMG7 interactions | 4.21e-06 | 319 | 28 | 6 | int:SMG7 | |
| Interaction | ARL16 interactions | 5.08e-06 | 83 | 28 | 4 | int:ARL16 | |
| Interaction | YTHDF3 interactions | 2.03e-05 | 246 | 28 | 5 | int:YTHDF3 | |
| Interaction | EYA2 interactions | 2.26e-05 | 121 | 28 | 4 | int:EYA2 | |
| Interaction | HELZ interactions | 2.51e-05 | 257 | 28 | 5 | int:HELZ | |
| Interaction | R3HDM2 interactions | 2.91e-05 | 129 | 28 | 4 | int:R3HDM2 | |
| Interaction | AGO2 interactions | 3.89e-05 | 472 | 28 | 6 | int:AGO2 | |
| Interaction | CNOT7 interactions | 4.01e-05 | 140 | 28 | 4 | int:CNOT7 | |
| Interaction | SIX1 interactions | 4.24e-05 | 49 | 28 | 3 | int:SIX1 | |
| Interaction | AR interactions | 4.31e-05 | 992 | 28 | 8 | int:AR | |
| Interaction | DAZL interactions | 4.60e-05 | 145 | 28 | 4 | int:DAZL | |
| Interaction | FUBP3 interactions | 5.00e-05 | 297 | 28 | 5 | int:FUBP3 | |
| Interaction | CPEB4 interactions | 6.12e-05 | 156 | 28 | 4 | int:CPEB4 | |
| Interaction | YTHDF2 interactions | 6.32e-05 | 312 | 28 | 5 | int:YTHDF2 | |
| Interaction | EGR2 interactions | 8.74e-05 | 171 | 28 | 4 | int:EGR2 | |
| Interaction | CNOT2 interactions | 1.02e-04 | 178 | 28 | 4 | int:CNOT2 | |
| Interaction | ZFP36 interactions | 1.09e-04 | 181 | 28 | 4 | int:ZFP36 | |
| Interaction | AGO1 interactions | 1.14e-04 | 183 | 28 | 4 | int:AGO1 | |
| Interaction | HNF1B interactions | 1.31e-04 | 190 | 28 | 4 | int:HNF1B | |
| Interaction | MAML1 interactions | 1.40e-04 | 73 | 28 | 3 | int:MAML1 | |
| Interaction | TLE3 interactions | 1.52e-04 | 376 | 28 | 5 | int:TLE3 | |
| Interaction | TXNL4A interactions | 1.64e-04 | 77 | 28 | 3 | int:TXNL4A | |
| Interaction | PRRC2A interactions | 1.78e-04 | 389 | 28 | 5 | int:PRRC2A | |
| Interaction | CNOT3 interactions | 1.82e-04 | 207 | 28 | 4 | int:CNOT3 | |
| Interaction | RBMS1 interactions | 1.82e-04 | 207 | 28 | 4 | int:RBMS1 | |
| Interaction | SOX7 interactions | 1.98e-04 | 82 | 28 | 3 | int:SOX7 | |
| Interaction | ZC3H7A interactions | 2.11e-04 | 215 | 28 | 4 | int:ZC3H7A | |
| Interaction | MEX3B interactions | 2.38e-04 | 222 | 28 | 4 | int:MEX3B | |
| Interaction | NOTCH2 interactions | 2.62e-04 | 423 | 28 | 5 | int:NOTCH2 | |
| Interaction | NUP35 interactions | 2.65e-04 | 424 | 28 | 5 | int:NUP35 | |
| Interaction | CNOT9 interactions | 2.77e-04 | 231 | 28 | 4 | int:CNOT9 | |
| Interaction | CNOT6L interactions | 2.87e-04 | 93 | 28 | 3 | int:CNOT6L | |
| Interaction | MAML3 interactions | 3.48e-04 | 20 | 28 | 2 | int:MAML3 | |
| Interaction | MED6 interactions | 3.65e-04 | 101 | 28 | 3 | int:MED6 | |
| Interaction | NOTCH4 interactions | 3.85e-04 | 21 | 28 | 2 | int:NOTCH4 | |
| Interaction | LZIC interactions | 4.63e-04 | 23 | 28 | 2 | int:LZIC | |
| Interaction | PRRC2B interactions | 4.67e-04 | 265 | 28 | 4 | int:PRRC2B | |
| Interaction | TNRC6A interactions | 5.74e-04 | 280 | 28 | 4 | int:TNRC6A | |
| Interaction | DDX6 interactions | 5.80e-04 | 503 | 28 | 5 | int:DDX6 | |
| Interaction | TNRC6B interactions | 5.90e-04 | 282 | 28 | 4 | int:TNRC6B | |
| Interaction | CSDE1 interactions | 6.06e-04 | 284 | 28 | 4 | int:CSDE1 | |
| Interaction | PUM1 interactions | 6.30e-04 | 287 | 28 | 4 | int:PUM1 | |
| Interaction | RPS20 interactions | 6.34e-04 | 513 | 28 | 5 | int:RPS20 | |
| Interaction | PRRC2C interactions | 6.55e-04 | 290 | 28 | 4 | int:PRRC2C | |
| Interaction | UBAP2L interactions | 7.25e-04 | 298 | 28 | 4 | int:UBAP2L | |
| Interaction | EIF4ENIF1 interactions | 7.43e-04 | 300 | 28 | 4 | int:EIF4ENIF1 | |
| Interaction | YTHDF1 interactions | 7.62e-04 | 302 | 28 | 4 | int:YTHDF1 | |
| Interaction | SP7 interactions | 7.81e-04 | 304 | 28 | 4 | int:SP7 | |
| Interaction | CNOT1 interactions | 7.91e-04 | 305 | 28 | 4 | int:CNOT1 | |
| Interaction | ISX interactions | 8.44e-04 | 31 | 28 | 2 | int:ISX | |
| Interaction | ATXN2 interactions | 8.60e-04 | 312 | 28 | 4 | int:ATXN2 | |
| Interaction | CNOT10 interactions | 9.66e-04 | 141 | 28 | 3 | int:CNOT10 | |
| Interaction | CPEB1 interactions | 1.07e-03 | 146 | 28 | 3 | int:CPEB1 | |
| Interaction | POU6F2 interactions | 1.11e-03 | 148 | 28 | 3 | int:POU6F2 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.43e-04 | 25 | 20 | 2 | 775 | |
| GeneFamily | DEAD-box helicases | 9.75e-04 | 42 | 20 | 2 | 499 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.43e-03 | 51 | 20 | 2 | 870 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.94e-05 | 822 | 28 | 7 | M6782 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP | 5.72e-05 | 199 | 28 | 4 | M8028 | |
| Coexpression | GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP | 5.83e-05 | 200 | 28 | 4 | M3316 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.56e-05 | 116 | 28 | 4 | gudmap_developingGonad_e18.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.52e-05 | 160 | 28 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 8.89e-05 | 66 | 28 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.50e-05 | 184 | 28 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 9.59e-05 | 359 | 28 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.15e-04 | 72 | 28 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.54e-04 | 397 | 28 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.82e-04 | 84 | 28 | 3 | gudmap_developingGonad_P2_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 2.31e-04 | 91 | 28 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 2.31e-04 | 91 | 28 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.62e-04 | 261 | 28 | 4 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_200 | 4.55e-04 | 24 | 28 | 2 | gudmap_developingGonad_e12.5_ovary_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 5.40e-04 | 806 | 28 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 5.58e-04 | 811 | 28 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.41e-06 | 166 | 28 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.00e-06 | 199 | 28 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| Disease | Seizures | 5.16e-05 | 218 | 28 | 4 | C0036572 | |
| Disease | nephroblastoma (is_implicated_in) | 7.85e-05 | 14 | 28 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Generalized hypotonia | 9.05e-05 | 15 | 28 | 2 | C1858120 | |
| Disease | Global developmental delay | 2.70e-04 | 133 | 28 | 3 | C0557874 | |
| Disease | Nephroblastoma | 5.36e-04 | 36 | 28 | 2 | C0027708 | |
| Disease | Intellectual Disability | 7.98e-04 | 447 | 28 | 4 | C3714756 | |
| Disease | body fat percentage | 1.10e-03 | 488 | 28 | 4 | EFO_0007800 | |
| Disease | feeling emotionally hurt measurement | 1.30e-03 | 56 | 28 | 2 | EFO_0009599 | |
| Disease | Hallux valgus | 1.49e-03 | 60 | 28 | 2 | HP_0001822 | |
| Disease | hearing impairment | 3.90e-03 | 98 | 28 | 2 | C1384666 | |
| Disease | grip strength measurement | 4.35e-03 | 350 | 28 | 3 | EFO_0006941 | |
| Disease | Seizures, Focal | 4.38e-03 | 104 | 28 | 2 | C0751495 | |
| Disease | Myoclonic Seizures | 4.38e-03 | 104 | 28 | 2 | C4317123 | |
| Disease | Tonic - clonic seizures | 4.38e-03 | 104 | 28 | 2 | C0494475 | |
| Disease | Dupuytren Contracture | 4.71e-03 | 108 | 28 | 2 | EFO_0004229 | |
| Disease | monocyte percentage of leukocytes | 4.77e-03 | 731 | 28 | 4 | EFO_0007989 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.85e-03 | 364 | 28 | 3 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | eosinophil percentage of leukocytes | 5.12e-03 | 746 | 28 | 4 | EFO_0007991 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KNTNTINNGTQQQAQ | 46 | P26196 | |
| KNANFTGPNQTSSNS | 21 | P35368 | |
| NVNPASAGNQTQKTQ | 161 | Q5VW38 | |
| SHQPPSNLNQNSANN | 491 | Q92585 | |
| SNLNQNSANNQGSVL | 496 | Q92585 | |
| QLSGFNTNQSNNVLQ | 1096 | Q92619 | |
| NCKNSSTNNNQTQDP | 6 | O75409 | |
| QPNNLGTNSLNKQHN | 581 | Q96JK9 | |
| QNQQTPNSAILTGNK | 311 | Q86T24 | |
| NAQNINPSSSQNSQN | 851 | P42262 | |
| NSANQQTTPQAQQGQ | 486 | Q14671 | |
| GNIKQNPNTQSLSQT | 476 | Q92771 | |
| AQLANQNKLAGNNSS | 586 | Q9P267 | |
| QSQGQGQSQNPNQNQ | 531 | Q96MM7 | |
| KNQQQQQGNNHTNGT | 371 | P49336 | |
| TLQGSNTQQKPASNQ | 41 | Q05469 | |
| ASNQGNSQPQQKYTV | 486 | Q8WZA2 | |
| ANNNNVFTKKTGNQQ | 471 | Q86VP1 | |
| GQQNKGAQSEQKNNS | 121 | Q96AH0 | |
| ASQQNQSGPSGNNQN | 341 | Q13148 | |
| SQSNQVNENGKNPSC | 406 | Q5HYW2 | |
| GNSNSQNKISNPSQQ | 721 | Q9HCM1 | |
| NQGQASSQSSNPSLN | 456 | Q15788 | |
| HSQNQNQPSPTQQSS | 256 | P78424 | |
| ENNNSSSNKQNQLSP | 191 | Q15475 | |
| QKQLNNSSVSSPQQN | 541 | Q9Y253 | |
| NLQKPTQSISQENTN | 121 | Q5JSZ5 | |
| QTQISNNYGNNPLNS | 201 | Q8N823 | |
| TNNNAKRATANNQQP | 81 | Q8NDV7 | |
| QQPQNNGEVQNSKNQ | 181 | Q8NDV7 |